Elsevier

Surgery

Volume 138, Issue 5, November 2005, Pages 899-904
Surgery

Original communication
Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer

https://doi.org/10.1016/j.surg.2005.04.014Get rights and content

Background

Gastric cancer continues to be a significant health problem around the world. Surgical resection with a lymph node dissection remains the only potentially curative treatment with gastric cancer. Determination of the extent of lymph node dissection required on the basis of actual node involvement in patients with gastric cancer is important as less extensive dissection may reduce postoperative morbidity and mortality rates. The current study examines the feasibility and reliability of sentinel lymph node biopsy in gastric cancer.

Methods

A total of 32 patients who underwent gastrectomy with extended lymphadenectomy were enrolled in this study. A total volume of 148 MBq (2 mL) technetium-99m–radiolabeled, filtered sulphur colloid solution was injected into the primary lesion under gastroscopy 2 hours before the operation. Lymph nodes were examined as soon as possible by a hand-held gamma probe during the operation, without significant manipulation of the stomach or greater omentum. A sentinel lymph node (SLN) was defined by a level of radioactivity 10 times higher than the background.

Results

Thirty-one of 32 patients had succesful SLN biopsy, with a success rate of 97%. The sensitivity, specificity, positive predictive value, and negative predictive value of SLN biopsy were 100%, 95%, 90%, and 100%, respectively.

Conclusions

SLN biopsy using gamma probe in gastric cancer is a feasible procedure with high sensitivity and accuracy. This technique may be of a great benefit to surgeons in planning the extend of lymph node dissection in gastric cancer.

Section snippets

Methods

A total of 32 (6 female) patients who underwent gastrectomy with extended lymphadenectomy, including the sampling of paraaortic lymph nodes, at the Department of Surgery, Ankara Numune Teaching and Research Hospital, Ankara, Turkey, from April 1999 to March 2003 were enrolled in this study.

Results

The 32 gastric cancer patients with a median age of 58 years (range, 34-69 years) were included. The clinicopathologic characteristics of patients enrolled in the study are summarized in Table I. There were no unexpected toxicities or complications related to administration of radioactive tracer.

The operations were uneventful in all patients. There was no intraoperative or in-hospital death. Six patients had some minor complications including prolonged abdominal drainage, delayed gastric

Discussion

The rationale for extended lymph node dissection is that it may achieve an R0 resection attributed to clearance of the metastatic lymph nodes and better locoregional tumor control, which should improve patient survival.25, 26, 27 However, the efficacy of lymph node dissection in gastric cancer is still controversial, and is debated between Western groups and Japanese groups. Several Japanese studies25, 28, 29, 30 reported favorable results with extended lymphadenectomy with positive nodes:total

Conclusion

SLN biopsy using a gamma probe in gastric cancer is a feasible procedure with high sensitivity and accuracy. We believe that SLN biopsy can identify lymph node involvement without adding substantially to the time, cost, or morbidity of the primary surgical procedure. This technique may be of benefit to surgeons in planning the extent of lymph node dissection in gastric cancer.

References (45)

  • H. Baba et al.

    Clinicopathological characteristics of stage 1 gastric cancer: comparison of macroscopic and microscopic findings

    Hepatogastroenterology

    (1997)
  • T. Yokota et al.

    Lymph node metastasis in early gastric cancer: how can surgeons perform limited surgery?

    Int Surg

    (1998)
  • H.J. Wanebo et al.

    Gastric carcinoma: does lymph node dissection alter survival?

    J Am Coll Surg

    (1996)
  • A. Cushieri et al.

    Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer:preliminary results of the MRC randomized controlled surgical trial

    Lancet

    (1996)
  • D.M. Dent et al.

    Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma

    Br J Surg

    (1988)
  • C.S. Robertson et al.

    A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer

    Ann Surg

    (1994)
  • Y. Kitagawa et al.

    Radio-guided sentinel node detection for gastric cancer

    Br J Surg

    (2002)
  • R.D. Halpert et al.

    Role of radiology in the diagnosis and staging of gastric malignancy

    Endoscopy

    (1993)
  • M. Thörn

    Lymphatic mapping and sentinel node biopsy: is the method applicable to patients with colorectal and gastric cancer?

    Eur J Surg

    (2000)
  • R.M. Cabanas

    An approach for the treatment of penile carcinoma

    Cancer

    (1977)
  • J.H. Wong et al.

    Lymphatic drainage of skin to a sentinel lymph node in a feline model

    Ann Surg

    (1991)
  • M.K. Lingam et al.

    Intraoperative identification of sentinel lymph node in patients with malignant melanoma

    Br J Cancer

    (1997)
  • Cited by (26)

    • Sentinel lymph node biopsy to direct treatment in gastric cancer. A systematic review of the literature

      2011, European Journal of Surgical Oncology
      Citation Excerpt :

      The mean and median percentages for the sensitivity were 85.4% and 88.9% respectively with a wide range from 45.5% to 100%. Low sensitivity percentages of less than 90% were observed in 13/21 studies.10–12,14,17,20–26 In two of the 13 studies better sensitivity percentage of 90–100% was obtained by using the combination method, 9,24 while one showed a similar result with IREE.18

    • Hyaluronic acid is a useful tool for intraoperative sentinel node detection in gastric cancer surgery

      2007, Surgery
      Citation Excerpt :

      Therefore, the detection of SN should be a great advantage for many patients with EGC, because the frequency of nodal metastasis is relatively low in EGC. Many feasibility studies have demonstrated promising results with respect to the detection rate and accuracy of SN in gastric cancer.5,12-18 However, there are still some practical problems in the clinical application of SN biopsy in EGC.

    • Gastroesophageal Carcinoma: Individualized Surgical Therapy

      2006, Surgical Oncology Clinics of North America
    • Sentinel Node Navigation Surgery for Upper Gastrointestinal Cancer

      2022, Cancer Metastasis Through the Lymphovascular System
    View all citing articles on Scopus
    View full text